What is ASEA?
Headquartered in Pleasant Grove, Utah, and established in 2007, ASEA operates at the intersection of biotechnology and wellness. The company specializes in the manufacturing of advanced products designed to support and replenish cellular healing processes. By leveraging proprietary redox signaling technology, ASEA has carved out a distinct niche within the global health and wellness industry. Its market position is defined by a commitment to scientific rigor and a robust distribution network that facilitates the delivery of its specialized health solutions to a diverse consumer base. The company's focus on cellular-level health provides a competitive advantage in an increasingly crowded wellness market, allowing it to maintain high levels of customer retention and brand loyalty.
How much funding has ASEA raised?
ASEA has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in ASEA
PPP
Public-Private Partnership
What's next for ASEA?
Looking ahead, the infusion of capital is expected to drive significant strategic initiatives, particularly in the areas of research and development and international market expansion. As the company transitions into this next phase of growth, management will likely prioritize the scaling of its manufacturing infrastructure to meet rising global demand. Furthermore, the strategic deployment of these funds will enable ASEA to deepen its investment in clinical studies, thereby reinforcing the scientific credibility of its product portfolio. By focusing on operational efficiency and market diversification, the company is poised to solidify its leadership in the cellular health space, ensuring sustained value creation for its stakeholders and continued innovation in its core product offerings.
See full ASEA company page
